Premature atherosclerosis in hiv-infected individuals focus on protease inhibitor therapy

AIDS

Volumn 15, Issue 3, 2001, Pages 329-334

  Depairon, Michèle ^a   Chessex, Sandra ^a   Sudre, Philippe ^a   Rodondi, Nicolas ^b   Doser, Nicole ^b   Chave, Jean Philippe ^c   Riesen, Walter ^d   Nicod, Pascal ^a   Darioli, Roger ^b   Telenti, Amalio ^a   Mooser, Vincent ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c La Source Hospital   (France)

^d KANTONSSPITAL   (Switzerland)

Author keywords

Antiretroviral therapy; Endocrine; Heart; Protease inhibitors; Reverse transcriptase inhibitors

Indexed keywords

CHOLESTEROL; LIPID; PROTEINASE INHIBITOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035895679     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200102160-00005     Document Type: Article

References (26)

1. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
2. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus : A cohort study
3. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
4. Fat distribution and metabolic changes in patients with HIV infection
5. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
6. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors
7. Effect of ritonavir on lipids and post-heparin lipase activity in normal subjects
8. Prediction of coronary heart disease using risk factor categories
9. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study
10. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysls of population-based prospective studies
11. Vascular complications associated with the use of HIV protease inhibitors
12. Severe premature coronary artery disease with protease inhibitors
13. Vascular complications associated with the use of HIV protease inhibitors
14. Sudden cardiac death in a patient on 2 years of highly active antiretroviral treatment: A case report
15. Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment ?
16. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
17. Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study
18. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery
19. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
20. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis. The Tromso Study
21. Reference values for intima-media thickness of carotid and femoral arteries in subjects aged 20-60 years without cardiovascular risk factors
22. The Swiss HIV cohort study: Rationale, organization and selected baseline characteristics
23. The pathogenesis of coronary artery disease and the acute syndromes
24. Do protease inhibitors increase the risk for coronary heart disease among HIV positive patients?
25. Effect of statins on risk of coronary disease: A meta-analysls of randomized controlled trials
26. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Projects populations